Results 61 to 70 of about 4,423,512 (307)
HPV vaccination of immunocompromised hosts. [PDF]
It is well-established that immunocompromised people are at increased risk of HPV-related disease compared with those who are immunocompetent. Prophylactic HPV sub-unit vaccines are safe and immunogenic in immunocompromised people and it is strongly ...
Bhatla, N+9 more
core +3 more sources
Current Approaches to the Management of Sentinel Node Procedures in Early Vulvar Cancer in Germany : A Web-Based Nationwide Analysis of Practices [PDF]
Background: Lymph node involvement is the most important prognostic factor for recurrence and survival in vulvar cancer. Sentinel node (SN) procedure can be offered in well-selected patients with early vulvar cancer.
Almstedt, Katrin+16 more
core +2 more sources
Introduction: Vulvar cancer is a rare condition affecting older women and accounts for 3–5% of all gynecological cancers. Primary surgical treatment involves the removal of a large amount of tissue for which reconstructive surgery is often necessary with
Vito Andrea Capozzi+9 more
doaj +1 more source
On a fundamental problem in the analysis of cancer registry data [PDF]
In epidemiology research with cancer registry data, it is often of primary interest to make inference on cancer death, not overall survival. Since cause of death is not easy to collect or is not necessarily reliable in cancer registries, some special methodologies have been introduced and widely used by using the concepts of the relative survival ratio
arxiv
Lipschutz ulcers: uncommon diagnosis of vulvar ulcerations [PDF]
Aetiological diagnosis of genital ulcers is still a challenge in clinical practice. The cause is mostly infectious, but it may otherwise be a presentation of a wide variety of pathologies, such as autoimmune (eg, Behçet’s disease), cancer or ...
Costa, Sara+3 more
core +1 more source
Vulvar Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.
Vulvar cancer is annually diagnosed in an estimated 6,470 individuals and the vast majority are histologically squamous cell carcinomas. Vulvar cancer accounts for 5% to 8% of gynecologic malignancies.
N. Abu-Rustum+40 more
semanticscholar +1 more source
Midline involvement as a risk factor for vulvar cancer recurrence [PDF]
Objective: This observational study was to identify risk factors for vulvar cancer recurrence. Materials and Methods: In the study 107 patients with primary vulvar cancer were analyzed.
Baidekalna, Ieva+3 more
core +1 more source
Background. In recent years, there has been an increase in the incidence of vulvar precancer (lichen sclerosus), as well as vulvar cancer. Since this disorder is rare, treatment planning and therapy itself are often suboptimal, which results in a high ...
A. V. Zharov+3 more
doaj +1 more source
History and Updates of the GROINSS-V Studies [PDF]
Surgical management of vulvar cancer is associated with high morbidity rates. The main aim of the GROINSS-V studies is reducing treatment-related morbidity by finding safe alternative treatment options in early-stage vulvar cancer patients.
Oonk, Maaike H.M.+2 more
core +1 more source
Atrophic vulvar lichen sclerosus evolving to an epidermoid carcinoma: about an uncommon case
Malignant tumors of the vulva are usually budding, ulcerated, or infiltrating. The fear of cancer must always be in mind, in front of any vulvar lesion.
Abderrahim Siati+4 more
doaj +1 more source